M Holdings Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

M Holdings Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,094	Closed	-$278K	–	205
2015 Q3	$278K	Sell	2,094 -107	-5%	-$18.4K	0.2%	143
2015 Q2	$388K	Hold	2,201	–	–	0.26%	113
2015 Q1	$380K	Sell	2,201 -20	-0.9%	-$3.43K	0.25%	120
2014 Q4	$364K	Buy	2,221 +169	+8%	+$28.1K	0.24%	123
2014 Q3	$329K	Buy	2,052 +256	+14%	+$39.4K	0.18%	128
2014 Q2	$264K	Sell	1,796 -12	-0.7%	-$1.66K	0.17%	144
2014 Q1	$251K	Buy	+1,808	New	+$272K	0.26%	100

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

M Holdings Securities's JAZZ Position: Q4 2015 in Review

M Holdings Securities sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2015, closing a stake of 2,094 shares — an estimated $278K sold.

M Holdings Securities first reported a position in JAZZ in Q1 2014 and held it in 7 quarters. The position peaked at $388K in Q2 2015. 345 funds tracked by Wall St. Rank hold JAZZ as of Q4 2015.

M Holdings Securities reported no remaining Jazz Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
M Holdings Securities sold 2,094 Jazz Pharmaceuticals shares in Q4 2015, an estimated $278K.
M Holdings Securities first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 7 quarters.
M Holdings Securities's Jazz Pharmaceuticals position peaked at $388K in Q2 2015.
345 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2015.

Based on M Holdings Securities's 13F filing for Q4 2015, filed 24 Feb 2016.